UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The implications of model-informed drug discovery and development for tuberculosis

Muliaditan, M; Davies, GR; Simonsson, USH; Gillespie, SH; Della Pasqua, O; (2016) The implications of model-informed drug discovery and development for tuberculosis. Drug Discovery Today , 22 (3) pp. 481-486. 10.1016/j.drudis.2016.09.004. Green open access

[thumbnail of Della Pasqua_Predict-TB - DDT final_MM.pdf]
Preview
Text
Della Pasqua_Predict-TB - DDT final_MM.pdf

Download (351kB) | Preview

Abstract

Despite promising advances in the field and highly effective first-line treatment, an estimated 9.6 million people are still infected with tuberculosis (TB). Innovative methods are required to effectively transition the growing number of compounds into novel combination regimens. However, progression of compounds into patients occurs despite the lack of clear understanding of the pharmacokinetic–pharmacodynamic (PK/PD) relations. The PreDiCT-TB consortium was established in response to the existing gaps in TB drug development. The aim of the consortium is to develop new preclinical tools in concert with an in silico model-based approach, grounded in PKPD principles. Here, we highlight the potential impact of such an integrated framework on various stages in TB drug development and on the dose rationale for drug combinations.

Type: Article
Title: The implications of model-informed drug discovery and development for tuberculosis
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.drudis.2016.09.004
Publisher version: http://dx.doi.org/10.1016/j.drudis.2016.09.004
Language: English
Additional information: Copyright © 2016. This manuscript version is published under a Creative Commons Attribution Non-commercial Non-derivative 4.0 International licence (CC BY-NC-ND 4.0). This licence allows you to share, copy, distribute and transmit the work for personal and non-commercial use providing author and publisher attribution is clearly stated. Further details about CC BY licences are available at http://creativecommons.org/licenses/by/4.0.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmacology
URI: https://discovery.ucl.ac.uk/id/eprint/1517996
Downloads since deposit
140Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item